Tumor location and IDH1 mutation may predict intraoperative seizures during awake craniotomy

Tal Gonen, Rachel Grossman, Razi Sitt, Erez Nossek, Raneen Yanaki, Emanuela Cagnano, Akiva Korn, Daniel Hayat, Zvi Ram

Research output: Contribution to journalArticlepeer-review

Abstract

Object. Intraoperative seizures during awake craniotomy may interfere with patients' ability to cooperate throughout the procedure, and it may affect their outcome. The authors have assessed the occurrence of intraoperative seizures during awake craniotomy in regard to tumor location and the isocitrate dehydrogenase 1 (IDH1) status of the tumor. Methods. Data were collected in 137 consecutive patients who underwent awake craniotomy for removal of a brain tumor. The authors performed a retrospective analysis of the incidence of seizures based on the tumor location and its IDH1 mutation status, and then compared the groups for clinical variables and surgical outcome parameters. Results. Tumor location was strongly associated with the occurrence of intraoperative seizures. Eleven patients (73%) with tumor located in the supplementary motor area (SMA) experienced intraoperative seizures, compared with 17 (13.9%) with tumors in the other three non-SMA brain regions (p < 0.0001). Interestingly, there was no significant association between history of seizures and tumor location (p = 0.44). Most of the patients (63.6%) with tumor in the SMA region harbored an IDH1 mutation compared with those who had tumors in non-SMA regions. Thirty-one of 52 patients (60%) with a preoperative history of seizures had an IDH1 mutation (p = 0.02), and 15 of 22 patients (68.2%) who experienced intraoperative seizures had an IDH1 mutation (p = 0.03). In a multivariate analysis, tumor location was found as a significant predictor of intraoperative seizures (p = 0.002), and a trend toward IDH1 mutation as such a predictor was found as well (p = 0.06). Intraoperative seizures were not associated with worse outcome. Conclusions. Patients with tumors located in the SMA are more prone to develop intraoperative seizures during awake craniotomy compared with patients who have a tumor in non-SMA frontal areas and other brain regions. The IDH1 mutation was more common in SMA region tumors compared with other brain regions, and may be an additional risk factor for the occurrence of intraoperative seizures.

Original languageEnglish
Pages (from-to)1133-1138
Number of pages6
JournalJournal of Neurosurgery
Volume121
Issue number5
DOIs
StatePublished - Nov 2014
Externally publishedYes

Keywords

  • Awake craniotomy
  • Brain tumors
  • Isocitrate dehydrogenase 1 mutation
  • Oncology
  • Seizures
  • Supplementary motor area

Fingerprint

Dive into the research topics of 'Tumor location and IDH1 mutation may predict intraoperative seizures during awake craniotomy'. Together they form a unique fingerprint.

Cite this